UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Keybank National Association OH

Keybank National Association OH boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.6% in the fourth quarter, HoldingsChannel.com reports. The firm owned 197,617 shares of the healthcare conglomerate’s stock after acquiring an additional 1,193 shares during the period. Keybank National Association OH’s holdings in UnitedHealth Group were worth $99,967,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently modified their holdings of UNH. AlphaMark Advisors LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $30,000. RPg Family Wealth Advisory LLC acquired a new position in UnitedHealth Group during the 3rd quarter valued at approximately $37,000. Legacy Investment Solutions LLC acquired a new stake in UnitedHealth Group in the third quarter worth $57,000. DecisionPoint Financial LLC grew its position in shares of UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after acquiring an additional 62 shares during the last quarter. Finally, FPC Investment Advisory Inc. lifted its position in UnitedHealth Group by 863.6% in the 4th quarter. FPC Investment Advisory Inc. now owns 106 shares of the healthcare conglomerate’s stock valued at $58,000 after purchasing an additional 95 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Down 1.6 %

Shares of NYSE:UNH opened at $467.21 on Tuesday. The firm has a 50 day simple moving average of $515.81 and a 200 day simple moving average of $556.09. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a market cap of $429.97 billion, a PE ratio of 30.14, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the prior year, the business earned $5.83 EPS. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.80%. The ex-dividend date of this dividend is Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 54.19%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on UNH shares. Stephens lifted their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a report on Thursday, December 5th. KeyCorp reiterated an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Oppenheimer lifted their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Barclays lowered their target price on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research note on Friday, January 17th. Finally, Piper Sandler lowered their price objective on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $629.32.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The stock was purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.